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Objectives: This study assessed the accuracy of the screening vascular physical examination for predicting asymptomatic
peripheral arterial disease (PAD) or subclinical atherosclerosis in asymptomatic and apparently healthy subjects.
Methods: A standardized physical examination and a carotid and femoral ultrasonography were administered to 2736
men and women aged 20 to 90 years old, with no personal history of cardiovascular disease (CVD) and no complaint
of neurologic, coronary, or lower limb symptom. We assessed the accuracy of auscultation for bruits and pulse
palpation for identifying the presence of significant carotid stenosis, carotid plaque, femoral plaque, and ankle-
brachial index (ABI) <0.9 at ultrasonography.
Results: The presence of a femoral bruit provided information on the presence of both an ABI <0.9 (positive likelihood
ratio [LR], 2.90; 95% confidence interval [CI], 1.63 to 5.16) and a femoral plaque (LR, 3.23; 95% CI, 2.22 to 4.71),
and this information was independent from the cardiovascular risk factors. The absence of both pedal pulses also provided
additional information, beyond risk factors, on the presence of an ABI <0.9 (LR, 3.57; 95% CI, 1.93 to 6.60). The
presence of a carotid bruit did not affect the likelihood of carotid stenosis, plaque, or intima-media thickness above the
median.
Conclusion: Unlike carotid auscultation, pulse palpation and auscultation for femoral bruits provided valuable informa-
tion on the presence of asymptomatic PAD and underlying atherosclerosis in apparently healthy subjects. ( J Vasc Surg
2007;46:1215-21.)Primary prevention of cardiovascular diseases (CVD) in
daily clinical practice is based on the screening of cardiovas-
cular risk factors and the assessment of an individual’s
cardiovascular risk, either by counting categoric risk factors
or by using a risk equation.1,2 Several subclinical CVD
markers, including intima-media thickness (IMT),3 extra-
coronary plaques,4 or ankle-brachial index (ABI)5 have
shown their ability to improve the cardiovascular risk assess-
ment. Taking these markers into account in a clinical deci-
sion process implies paraclinical examination (hand-held
Doppler imaging or duplex ultrasonography) and increases
the expense of medical care.6 The way to select subjects
who could benefit from these explorations is debated.
The physical examination appears to be the cornerstone
of clinical medicine in patients with no complaint and
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doi:10.1016/j.jvs.2007.08.022should be a key factor in the decision to perform further
examinations. Surprisingly, unlike symptomatic patients,7
the reliability of the physical examination is poorly known
in asymptomatic subjects and is not addressed in the CVD
prevention guidelines. The vascular physical examination in
a screening setting has been severely criticized by many
physicians. In the absence of complaint, such casual find-
ings would be poorly reproducible, would be unreliable,
and could be difficult to interpret. These doubts are due to
a lack of clinical evidence.
To our knowledge, no study has investigated the accu-
racy of a carotid and lower limb examination in detecting
subclinical atherosclerosis in asymptomatic patients. The
aim of this study was to assess the accuracy of the screening
clinical examination in detecting asymptomatic peripheral
arterial disease (PAD) and various markers of subclinical
atherosclerosis in asymptomatic subjects.
METHODS
Subjects. The Evaluation du Dépistage de la Coron-
aropathie (EVADEC) study is a prospective cohort study
that initially included 2977 apparently healthy asymptom-
atic subjects. Participants were recruited in our preventive
cardiology clinic between September 1995 and September
2004. The participants were referred for an evaluation of
their risk factors and a routine ambulatory cardiovascular
screening. To be eligible for recruitment, subjects had to be
aged 18 to 90 years and free of any personal history of
CVD, defined as myocardial infarction, stable or unstable
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any cardiovascular symptom, defined as chest pain at rest or
during exercise, dyspnea, claudication, or palpitation. Phy-
sicians from our teaching hospital referred 53% of the
participants, 27% were referred by their primary-care phy-
sician, and 20% were self-referred.
All participants attended a standardized examination
protocol, including medical history, physical examination,
blood hematology and biochemistry analysis, rest electro-
cardiography, cardiac cycloergometer exercise testing, and
imaging by carotid and femoral duplex ultrasound. Self-
reported medical history was completed by a systematic
confirmation, including the review of all the medical
records available in our hospital database, the interview of
the patient’s regular physician, and consultation of the local
coronary heart disease (CHD) registry belonging to the
Monitoring of Trends and Determinants in Cardiovascular
Disease (MONICA) World Health Organization (WHO)
project.8 As a result of this thorough investigation, 241 of
the 2977 initially eligible subjects were excluded because of
non-self-reported history of coronary artery disease or
stroke. Each subject gave an informed consent, and autho-
rization from the appropriate ethics committee was ob-
tained. The present cross-sectional study analyzed the data
collected in the 2736 included subjects.
Risk factors. On the day of screening, all subjects
provided information about their cardiovascular risk factors
and lifestyle through a standardized questionnaire, derived
from the MONICA population survey,9 done in the same
region and administered by the same physician throughout
the whole study. Recorded data included a complete med-
ical history concerning CVD risk factors, history of cardio-
vascular disease, possible cardiovascular symptoms, medi-
cation, alcohol consumption, and social and professional
data.
The risk factors taken into account were age (45 years
for men, 55 years for women), current cigarette smoking,
hypertension (blood pressure 140 mm Hg systolic or 90
mm Hg diastolic, or documented use of antihypertensive
drugs), diabetes mellitus (fasting glucose level126 mg/dL
or documented use of antidiabetic drugs), hypercholesterol-
emia (low-density lipoprotein cholesterol4.14 mmol/L or
documented use of lipid-lowering drugs), low high-density
lipoprotein cholesterol level (1.03 mmol/L for men,1.29
mmol/L for women), family history of premature coronary
heart disease (CHD;55 years in father or brother,65 years
in mother or sister), and overweight (body mass index 25
kg/m2).
Four levels of leisure time physical activity were de-
fined: no regular physical activity, mild physical activity (ie,
less than once a week), moderate physical activity (ie, 20
minutes at least once or twice a week), and high physical
activity (ie, 20 minutes three times a week or more).10
Metabolic syndrome was defined according the Na-
tional Cholesterol Education Program definition.1 Baseline
absolute cardiovascular risk was assessed by using a 10-year
Framingham risk function.11Physical examination. All the subjects underwent a
standardized physical examination that included measure-
ment of blood pressure, heart rate, height, weight, waist
circumference and hip circumference, pulse examination,
and auscultation for bruits. To assure comparability of the
findings, all 2736 patients were examined by the same
physician (D. T.), who was specially trained for the study.
The mean of two blood pressure measurements taken at
rest before exercise testing was used for analysis.
The vascular physical examination included pulse pal-
pation and auscultation for bruits. For both lower limbs,
any of the femoral, popliteal, posterior tibial (PT), and
dorsalis pedis (DP) pulses have been coded as present or
absent. Diminished pulses have been coded as present.
Auscultation for systolic bruits included the carotid, iliac
and femoral area and was performed with the bell of the
stethoscope, using a light pressure.
To assess interobserver variability, a subsample of 500
patients underwent the same standardized physical exami-
nation performed again by another physician who was
blinded to the results of the initial examination. Twelve
different physicians were involved for this validation. Inter-
rater agreement rates were 96% for carotid auscultation,
97% for femoral auscultation, 92% for PT palpation, and
92% for DP palpation.
Asymptomatic peripheral arterial disease and markers
of subclinical atherosclerosis. Brachial and ankle arterial
blood pressures in both limbs were measured, and we
calculated the ABI as the higher of the DP or PT arterial
Doppler blood pressure divided by the higher brachial
arterial Doppler blood pressure. An ABI of0.90 indicates
the presence of PAD with high sensitivity and specificity.12
Asymptomatic PAD was therefore defined as an ABI0.9.
An ABI 0.9 cannot be considered as a good marker of
asymptomatic PAD in patients with incompressible arteries
(ie, ABI 1.3). For this reason, these 303 patients were
excluded from analyses concerning the prediction of an
ABI 0.9. These analyses thus compared patients with an
ABI 0.9 with those with a “normal” ABI of 0.9 to 1.3.
Markers of subclinical atherosclerosis were assessed by
an ultrasonography examination of the arteries. The physi-
cian who performed the exploration was blind for the results
of the medical history and physical examination, including
blood pressure measurements. The bilateral common and
internal carotid arteries and femoral artery scanning were
performed using an ATL UM9 high-definition imaging sys-
tem (Advanced Technology Laboratory, Bothell, Wash) with
a 7.4-MHz transducer.
The IMT was defined as the distance between the
media-adventitia interface and the lumen-intima interface,
avoiding the sites of plaque. The IMT was measured on the
right and left common carotid arteries, on the far wall
exclusively, at three points at two locations on each artery,
proximal and middle with about 10- to 15-mm intervals,
the most cranial point being 15- to 20-mm from the
bifurcation. Standard flow velocity criteria were used for
grading the severity of carotid stenosis.13 Internal, com-
mon carotid, and femoral plaques were defined as a distinct
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or a focal protrusion into the lumen of the vessel, or both.
Statistical analysis. Analysis of variance and 2 tests
were used for comparisons between groups. A two-sided
value of P  .05 was considered statistically significant.
Positive and negative likelihood ratios and 95% confidence
interval (95% CI) for examination findings in relation to the
presence of various markers of subclinical atherosclerosis
were calculated.14 A positive likelihood ratio (LR) ex-
presses the odds that an abnormal clinical finding would be
expected in a patient with the target subclinical marker vs
one without. A negative likelihood ratio (LR) expresses the
odds that a normal clinical finding would be expected in a
patient with the target subclinical marker vs one without. The
LR is [sensitivity/(1 – specificity)] and the LR is [(1 –
sensitivity)/specificity].15 The more useful a clinical finding is,
the highest itsLR is (trends to) and the smallest itsLR is
(trends to 0). Crude odds ratios (OR) with 95% CI were also
calculated and were equal toLR/LR.
The next step was to determinate whether a given
clinical finding was able to provide additional information,
beyond classical risk factors, on the presence of markers of
Table I. Risk factors and results of noninvasive testing acc
auscultation and pulse palpation)
Variables*
Vascular physical
Normal (n  2342)
Risk factors
Age 51.7  10.7
Men 1454 (62.1)
Current smoking 554 (23.7)
Diabetes† 152 (6.5)
Hypertension† 1082 (46.2)
Hypercholesterolemia† 1630 (69.6)
Low HDL cholesterol† 398 (17.0)
Family history of CVD† 257 (11.0)
No or mild physical activity† 1886 (80.5)
Metabolic syndrome† 414 (17.7)
Physical examination
Systolic blood pressure 136.5  17.2
Diastolic blood pressure 82.8  8.9
Body mass index (kg/m2) 25.8  4.3
Waist circumference 89.2  12.3
Presence of a carotid bruit 0 (0)
Presence of a femoral bruit 0 (0)
PT or DP pulse absent 0 (0)
PT and DP pulses absent 0 (0)
Ultrasonography
Ankle-brachial index
 0.9 89 (3.8)
0.9-1.3 2000 (85.4)
1.3 253 (10.8)
Carotid stenosis (50%) 95 (4.1)
Carotid plaque (yes) 530 (22.6)
Intima-media thickness 0.64  0.14
Femoral plaque (yes) 568 (24.3)
2 plaques 533 (22.8)
HDL, high-density lipoprotein; CVD, cardiovascular; PT, posterior tibial; D
*Continuous data are presented with the standard deviation; categoric data
†For definitions of risk factors, see the Methods section.subclinical atherosclerosis. To do so, adjusted ORs werederived from multivariate logistic models, with markers of
subclinical atherosclerosis as binary outcome variable, and
sex, Framingham 10-year risk, and the presence of the
studied clinical finding as explicative variables. To investi-
gate if the accuracy of clinical findings depends on the risk
factor level, we tested statistical interactions between risk
score and clinical findings. Data were analyzed using the
STATA 9.0 statistical software (StataCorp LP, College
Station, Tex).
RESULTS
The mean age of the 2736 subjects at enrollment was
52 years, less than two-thirds were men (Table I), and 40%
of the sample had none or one major CVD risk factor. The
median Framingham 10-year risk of CHD was 8% (inter-
quartile range, 4.4 to 13.3). The most represented risk
factors were dyslipidemia and hypertension, and 30% of the
participants were currently receiving lipid-lowering therapy.
After the initial clinical examination, 394 of the partic-
ipants (14.5%) had one or more of the following: bruit at
auscultation, absent PT pulse, or absent DP pulse. An
absent DP pulse was found in 164 (6.0%) patients and an
g to findings at vascular physical examination (bruit
ination result
Total (n  2736) PAbnormal (n  394)
56.2  11.3 52.3  10.9 .001
207 (52.5) 1661 (60.7) .001
95 (24.1) 649 (23.7) .84
52 (13.2) 204 (7.5) .001
226 (58.0) 1308 (47.9) .001
284 (72.1) 1914 (70.0) .32
71 (18.0) 469 (17.2) .63
35 (8.9) 292 (10.7) .23
344 (87.3) 2230 (81.5) .001
96 (24.7) 510 (18.7) .001
141.2  18.3 137.2  14.4 .001
83.1  9.2 82.9  9.0 .64
26.7  4.9 25.9  4.4 .001
90.9  13.3 89.5  12.5 .01
81 (20.6) 106 (3.9) —
86 (21.8) 104 (3.8) —
270 (68.5) 270 (9.9) —
84 (21.3) 84 (3.1) —
.005
28 (7.1) 117 (4.3)
316 (80.2) 2316 (84.7)
50 (12.7) 303 (11.1)
19 (4.8) 114 (4.2) .48
118 (30.0) 648 (23.7) .002
0.66  0.14 0.64  0.14 .001
137 (34.8) 705 (25.8) .001
132 (33.5) 665 (24.3) .001
rsalis pedis.
umber (%).ordin
exam
P, do
are nabsent PT pulse in 195 (7.1%). Bilateral absent PT pulse
e.
se.
JOURNAL OF VASCULAR SURGERY
December 20071218 Cournot et alwas found in 147 subjects (5.4%) and bilateral absent DP in
117 (4.3%). Participants with an abnormal vascular physical
examination were older and more often women. Dyslipide-
mia, hypertension, diabetes, insufficient physical activity,
obesity, and metabolic syndrome were more frequent in
those with an abnormal result on physical examination. The
ultrasonography examination result was abnormal in 1159
(43%) participants. The most prevalent marker of subclini-
cal atherosclerosis was the presence of femoral plaque. All
markers, except carotid stenosis, were significantly more
frequently found in subjects with an abnormal clinical
examination result.
The presence of a carotid bruit had a poor accuracy for
the detection of carotid abnormalities (Table II). The
presence or the absence of a carotid bruit does not affect
the likelihood of carotid stenosis, carotid plaque, or IMT
above the median. Conversely, the clinical examination of
the lower limbs was more useful (Table III). The presence
of a femoral bruit increased the likelihood of both the
presence of a femoral plaque and an ABI0.9. The absence
of DP pulse, PT pulse, or both, increased the likelihood of
ABI 0.9 and had a significant but slighter effect on the
likelihood of femoral plaque. The absence of femoral bruit
had a moderate impact on the likelihood of an ABI 0.9
and a minimal impact on the likelihood of femoral plaque.
The presence of both DP and PT had a minimal impact on
the likelihood of these markers. The clinical findings that
Table II. Accuracy of carotid auscultation for the detectio
Physical sign Subclinical marker to detect LR (95%
Carotid Bruit Ipsilateral ICA stenosis 50% 0.90 (0.34-2
Ipsilateral carotid plaque 1.14 (0.75-1
IMT above the median 0.74 (0.50-1
OR, odds ratio; CI, confidence interval; LR, positive likelihood ratio (odd
subclinical marker vs one without);LR, negative likelihood ratio (odds tha
marker vs one without); ICA, internal carotid artery; IMT, intimal-media t
*OR adjusted for sex and 10 year Framingham risk of coronary heart diseas
Table III. Accuracy of physical findings for the detection
Physical sign Subclinical marker to detect LR ratio (9
Femoral bruit Ipsilateral ABI 0.9 2.90 (1.63-
Ipsilateral femoral plaque 3.23 (2.22-
Absent DP pulse Ipsilateral ABI 0.9 2.01 (1.17-
Ipsilateral femoral plaque 1.49 (1.09-
Absent PT pulse Ipsilateral ABI 0.9 1.80 (1.08-
Ipsilateral femoral plaque 1.47 (1.11-
Absent DP and
PT pulses
Ipsilateral ABI 0.9 3.57 (1.93-
Ipsilateral femoral plaque 1.69 (1.10-
OR, Odds ratio; CI, confidence interval;LR, positive likelihood ratio (odd
subclinical marker vs one without);LR, negative likelihood ratio (odds tha
marker vs one without); ABI, ankle-brachial index; DP, dorsalis pedis; PT,
*ORs adjusted for sex and 10-year Framingham risk of coronary heart diseaprovided significant additional information on the likeli-hood of ABI 0.9, beyond the risk factors, were a femoral
bruit and the absence of pedal pulses. That was true for
femoral bruit only when predicting the presence of a fem-
oral plaque.
We performed a separate analysis for patients with and
without diabetes (Table IV). Despite larger confidence
intervals due to the smaller sample sizes,LRs were signif-
icantly larger than 1 in both diabetic and nondiabetic
patients. Despite a trend in higher LRs in diabetic patients,
the LR values between diabetic and nondiabetic patients
were not significantly different.
As shown in the Fig as an example based on femoral
bruit, the LRs for the clinical findings were similar whatever
the CVD risk. There was no significant statistical interac-
tion between Framingham absolute risk and clinical find-
ings in logistic models.
DISCUSSION
The usefulness of clinical examination in patients with
complaint of neurologic or leg symptoms is not in doubt,
but some physicians have criticized the utility of findings at
systematic screening examination in patients with no his-
tory of CVD and no complaint.16 In our study, LRs have
been retrieved above 2 or 3 for pulse palpation and bruit
auscultation, and the prevalence of the disease was suffi-
ciently high to ensure a substantial increase in the proba-
different types of carotid sub-clinical atherosclerosis
LR (95% CI)
OR (95% CI)
Crude Adjusted*
1.00 (0.97-1.04) 0.90 (0.34-2.39) 0.90 (0.32-2.47)
1.00 (0.98-1.01) 1.15 (0.74-1.80) 1.10 (0.68-1.73)
1.01 (0.99-1.03) 0.72 (0.48-1.10) 0.69 (0.46-1.04)
an abnormal clinical finding would be expected in a patient with the target
mal clinical finding would be expected in a patient with the target subclinical
ss.
fferent types of lower limb subclinical atherosclerosis
) –LR (95% CI)
OR (95% CI)
Crude Adjusted*
0.93 (0.88-0.98) 3.11 (1.66-5.83) 2.96 (1.55-5.62)
0.95 (0.92-0.97) 3.42 (2.31-5.07) 3.17 (2.09-4.79)
0.94 (0.88-1.00) 2.14 (1.18-3.88) 2.04 (1.11-3.75)
0.97 (0.95-0.99) 1.54 (1.10-2.14) 1.31 (0.92-1.86)
0.94 (0.88-1.01) 1.91 (1.07-3.39) 1.81 (1.00-3.26)
0.97 (0.94-0.99) 1.52 (1.12-2.07) 1.19 (0.86-1.65)
0.93 (0.88-0.99) 3.84 (1.99-7.43) 3.71 (1.88-7.32)
0.98 (0.97-1.00) 1.72 (1.10-2.69) 1.46 (0.90-2.35)
an abnormal clinical finding would be expected in a patient with the target
mal clinical finding would be expected in a patient with the target subclinical
ior tibial.n of
CI)
.41)
.75)
.10)
s that
t a nor
hickneof di
5% CI
5.16)
4.71)
3.45)
2.04)
3.01)
1.96)
6.60)
2.60)
s that
t a nor
posterbility of disease. Conversely, whatever the physical sign, the
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presence of subclinical atherosclerosis or PAD.
As in a previous study conducted in asymptomatic
patients,17 we found that the presence of a femoral bruit
increases the likelihood of PAD, defined by an ABI0.90,
and this information was independent from the cardiovas-
cular risk factors. We confirmed this finding in younger
subjects and extended it to the prediction of femoral
plaque. The absence of pedal pulses also provided addi-
tional information on asymptomatic PAD, but when com-
pared with previous studies,18-20 we found a poorer accu-
racy of pulse palpation for the identification of PAD.
Actually, the above-cited studies included older and
hyperlipemic17 or diabetic18,19 patients and did not sys-
tematically exclude subjects with symptoms18 or history of
CVD.17,19 The prevalence of PAD in those studies was
therefore twofold to threefold higher than in the present
study. Moreover, a difference should be made between the
clinical relevance provided to the physician by the presence
of plaques and ABI. Whereas plaques are a prognostic
marker of CVD, an ABI 0.9 is a sign of asymptomatic
PAD, implying practical and immediate therapeutic mea-
sures.21
We found that the presence of a carotid bruit did not
affect the likelihood of carotid stenosis, plaque, or IMT
above the median. Indeed, the clinical usefulness of carotid
auscultation in asymptomatic patients is controversial. Sev-
eral studies have reported a good accuracy of cervical bruits
for carotid stenosis in symptomatic patients,22-24 whereas
others concluded that cervical bruits were not sufficiently
Table IV. Positive likelihood ratios* according to the pre
With diabetes (n 204)
Femoral bruit vs ABI 0.9 4.43 (1.05-18.6)
Absent pedal pulses vs ABI 0.9 4.43 (1.78-11)
Femoral bruit vs femoral plaque 3.02 (1.63-7.4)
ABI, Ankle-brachial index.
*Presented with 95% confidence intervals.
Fig. Accuracy of femoral bruit for the prediction of lower limb
subclinical atherosclerosis according to tertiles of pretest Framing-
ham risk. Error bars represent 95% confidence intervals.predictive.25 These studies were based on angiography asthe gold standard. There are many causes for bruits in the
neck, and the difference between vascular bruits and trans-
mitted murmurs is sometimes hard to make in clinical
practice.
In this study, we decided to focus on the interpretation
of any bruit heard at a vascular auscultation site, whatever
its origin. It could account for a part of the lack of accuracy
of carotid auscultation in our study and in the literature. We
found no study in the literature conducted in healthy
asymptomatic subjects that assessed the accuracy of carotid
bruit in the detection of carotid atherosclerosis. However,
it has been demonstrated in community-based studies that
the presence of an asymptomatic carotid bruit is associated
with the long-term incidence of stroke, myocardial infarc-
tion, and death.26,27 Bruits can also be a marker of systemic
disease. That is why, despite the lack of accuracy for detect-
ing subclinical carotid atherosclerosis, carotid auscultation
should continue to be part of any screening clinical exam-
ination for prognostic purposes.
Study limitations and strengths. Our study included
a large sample of men and women from all age ranges with
neither a personal history of CVD nor complaint of coro-
nary or leg symptoms. Thus, unlike the previous screening
studies,18-22 all subjects were asymptomatic and apparently
healthy. Our patients are therefore similar to those seen in
clinical practice for cardiovascular risk assessment and CVD
screening. To the best of our knowledge, the present study
is also the first to take into account a physical examination
and ultrasonographic assessment of both carotid and lower
limb arteries. This allows a coherent approach in the same
study because physicians usually perform auscultation and
palpation of the arteries in the same examination. A notice-
able interobserver variability in the cardiovascular examina-
tion has been reported.16 To avoid this bias, all patients
were examined by the same trained physician.
Our sample was not strictly population-based, and this
might be considered as a limitation to the study for the
generalization of our results. Patients were self-referred or
referred by their physician, perhaps accounting for a
healthy-screenee effect. We could also expect a higher risk
level in our participants. Indeed, the prevalence of hyper-
tension and dyslipidemia were higher than the prevalence
found in the general population of the same region
(MONICA-Toulouse).28 In this study, the prevalence of
diabetes, smoking, and obesity was similar to the general
population in France. Subjects with an ABI 1.3 were
excluded from analyses for the prediction of asymptomatic
of diabetes
out diabetes (n 2532) Total (n  2736) Interaction P 
2.73 (1.45-5.12) 2.90 (1.63-5.16) NS
3.0 (1.39-6.49) 3.57 (1.93-6.60) NS
3.45 (2.31-5.14) 3.23 (2.22-4.71) NSsence
WithPAD. Given that the prevalence of diabetes is higher in
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6.8%), diabetic patients were under-represented in the sam-
ple used for LR calculations. This could account for a bias in
the interpretation of the results.
Another problem could be that, according to the
Bayes theorem, the predictive value of a clinical sign
depends not only on the sensitivity and specificity of the
test but also on the prevalence of the disease (subclinical
atherosclerosis) in the population. Nevertheless, we can
reasonably rule out the eventuality that LRs would have
been overestimated or underestimated because, unlike
predictive values, LRs are independent from the preva-
lence. That is why we did not present any post-test
probability (positive or negative predictive values).
Our analyses were mostly based on pulse palpation and
bruit auscultation. Several other interesting physical find-
ings, but less systematic in the integrated screening physical
examination, such as capillary refill time, venous filling
time, or the Buerger test have not been investigated. These
examinations are probably more adapted to a context of
complaint of leg symptoms. Moreover, the assessment of
asymptomatic PAD was based on the ABI calculation. We
did not perform other noninvasive procedures such as
digital pressure measurement or toe/brachial index calcu-
lation that could have provided additional information,
particularly in the assessment of subjects with an ABI1.3.
CONCLUSION
Although carotid auscultation seems not to bring reliable
information on underlying atherosclerosis, physical examina-
tion of the lower limbs provides valuable information on the
presence of PAD and subclinical atherosclerosis. The vascular
physical examination should continue to be considered as a
part of any screening physical examination.
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